Skip to main content
Erschienen in: Clinical Rheumatology 2/2021

07.07.2020 | Original Article

Patients with asthma have a higher risk of systemic lupus erythematosus: a systematic review and meta-analysis

verfasst von: Nipith Charoenngam, Ben Ponvilawan, Wasit Wongtrakul, Patompong Ungprasert

Erschienen in: Clinical Rheumatology | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Objective

This study aimed to investigate the association between asthma and risk of systemic lupus erythematosus (SLE) using systematic review and meta-analysis technique.

Methods

Potentially eligible studies were identified from Medline and EMBASE databases from inception to March 2020 using search strategy that comprised of terms for “asthma” and “systemic lupus erythematosus.” Qualified cohort study must consist of one cohort of patients with asthma and another cohort of individuals without asthma. Then, the study must report relative risk (RR) with 95% confidence intervals (95% CIs) of incident SLE between the two groups. Qualified case–control studies must consist of cases with SLE and controls without SLE. Then, the study must explore their history of asthma. Odds ratio (OR) with 95% CIs of the association between asthma status and SLE must be reported. Point estimates and standard errors were extracted from each study and were combined using the generic inverse variance method.

Results

A total of 21,486 articles were identified. After two rounds of independent review by three investigators, three cohort studies and seven case–control studies met the eligibility criteria and were included into the meta-analysis. Patients with asthma had a significantly higher risk of SLE compared with individuals without asthma with the pooled odds ratio of 1.37 (95% CI 1.14–1.65; I2 67%). Funnel plot was symmetric and did not suggest the presence of publication bias.

Conclusions

The current study found a significant association between asthma and increased risk of SLE.
Key Points
• Studies have suggested an elevated risk of systemic lupus erythematosus among patients with asthma; however, the results from existing studies are inconsistent.
• This meta-analysis included data from three cohort studies and seven case-–control studies.
• A significant association between asthma and elevated risk of systemic lupus erythematosus was observed, with the pooled odds ratio of 1.37 (95% CI 1.14–1.65; I2 67%).
Anhänge
Nur mit Berechtigung zugänglich
Literatur
9.
Zurück zum Zitat Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001--2009 (2011). MMWR Morb Mortal Wkly Rep 60 (17):547–552 Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001--2009 (2011). MMWR Morb Mortal Wkly Rep 60 (17):547–552
13.
Zurück zum Zitat Goldman JA, Klimek GA, Ali R (1976) Allergy in systemic lupus erythematosus. IgE levels and reaginic phenomenon. Arthritis Rheum 19(4):669–676CrossRefPubMed Goldman JA, Klimek GA, Ali R (1976) Allergy in systemic lupus erythematosus. IgE levels and reaginic phenomenon. Arthritis Rheum 19(4):669–676CrossRefPubMed
14.
Zurück zum Zitat Sequeira JF, Cesic D, Keser G, Bukelica M, Karanagnostis S, Khamashta MA, Hughes GRV (1993) Allergic disorders in systemic lupus erythematosus. 2 (3):187-191:10.1177/096120339300200311 Sequeira JF, Cesic D, Keser G, Bukelica M, Karanagnostis S, Khamashta MA, Hughes GRV (1993) Allergic disorders in systemic lupus erythematosus. 2 (3):187-191:10.1177/096120339300200311
22.
24.
Zurück zum Zitat DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMed DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMed
34.
Zurück zum Zitat Jiménez-Morales S, Velázquez-Cruz R, Ramírez-Bello J, Bonilla-González E, Romero-Hidalgo S, Escamilla-Guerrero G, Cuevas F, Espinosa-Rosales F, Martínez-Aguilar NE, Gómez-Vera J, Baca V, Orozco L (2009) Tumor necrosis factor–α is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population. Human Immunology 70(4):251–256. https://doi.org/10.1016/j.humimm.2009.01.027CrossRefPubMed Jiménez-Morales S, Velázquez-Cruz R, Ramírez-Bello J, Bonilla-González E, Romero-Hidalgo S, Escamilla-Guerrero G, Cuevas F, Espinosa-Rosales F, Martínez-Aguilar NE, Gómez-Vera J, Baca V, Orozco L (2009) Tumor necrosis factor–α is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population. Human Immunology 70(4):251–256. https://​doi.​org/​10.​1016/​j.​humimm.​2009.​01.​027CrossRefPubMed
Metadaten
Titel
Patients with asthma have a higher risk of systemic lupus erythematosus: a systematic review and meta-analysis
verfasst von
Nipith Charoenngam
Ben Ponvilawan
Wasit Wongtrakul
Patompong Ungprasert
Publikationsdatum
07.07.2020
Verlag
Springer International Publishing
Erschienen in
Clinical Rheumatology / Ausgabe 2/2021
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05279-x

Weitere Artikel der Ausgabe 2/2021

Clinical Rheumatology 2/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.